Utility of coagulation analyses to assess thromboprophylaxis with dalteparin in intensive care unit patients.

Nina Gjerde AndersenMarie-Christine MowinckelKjetil SundePer Morten SandsetSigrid Beitland

Published in: Acta anaesthesiologica Scandinavica (2020)

Intensive care unit patients receiving dalteparin prophylaxis had half of patients within prophylactic peak aFXa target range. Peak aFXa levels was affected by administered dalteparin dose, but not presence of VTE, major bleeding or AKI with RRT.

Keyphrases

intensive care unit
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
venous thromboembolism
prognostic factors
acute kidney injury
atrial fibrillation
direct oral anticoagulants